Doug Liu, Mark Gladwell, Laura Furmanski
Doug Liu is retiring from his role as senior vice president of global operations at Qiagen, CEO Peer Schatz said during an earnings call this week. He will be succeeded by Mark Gladwell, who joined the company from Alere, where he most recently served as senior vice president of global operations.
In addition, Schatz said that Laura Furmanski, senior vice president of the bioinformatics business area, has resigned from the company. A search for her successor is in an advanced stage, Schatz said.
Illumina has named Gary Guthart to its board of directors, effective Dec. 1, 2017. Guthart is president and CEO of Intuitive Surgical, which makes robots to assist with minimally invasive surgery. He has held a variety of roles at Intuitive Surgical since 1996 and previously developed foundational technology for computer-enhanced surgery at SRI International, which was formerly the Stanford Research Institute. He also served on the board of directors at Affymetrix from 2009 until it was acquired by Thermo Fisher Scientific in 2016.
Pacific Biosciences has hired Kathy Ordoñez as chief commercial officer. Ordoñez has been a member of PacBio's board of directors since 2014 and will continue in that role as well. Ordoñez was most recently CEO of RainDance Technologies. She was also previously senior vice president at Quest Diagnostics where she led the company's R&D efforts and provided oversight to businesses commercializing diagnostic products and testing services. She served as CEO at Celera and was a founder of Celera Diagnostics before the company was acquireid by Quest Diagnostics. She also held several positions at Hoffmann-La Roche, including overseeing the formation of Roche Molecular Systems.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.